A Phase 1 Study of ABT-888 (Veliparib) in Combination With Weekly Carboplatin and Paclitaxel in Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 08 Jul 2015
At a glance
- Drugs Veliparib (Primary) ; Carboplatin; Paclitaxel
- Indications Advanced breast cancer; Solid tumours
- Focus Adverse reactions
- 07 Jun 2017 Biomarkers information updated
- 02 Jun 2015 Results (n=27) presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 22 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.